Compare Danaos Corporation (DAC) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs Nuwellis Inc — how do they compare? Danaos Corporation trades at $169.09 (market cap $3.10B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Danaos Corporation is far larger — about 1409.1× Nuwellis Inc's market cap, and Danaos Corporation pays a 2.35% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaos Corporation for 25 Days and Nuwellis Inc for 26 Days on average.
| DAC | NUWE | |
|---|---|---|
Market Cap | $3.10B | $2.20M |
Volume | 286,008 | 121,544 |
Sector | Industrials | Health |
52-Week High | $170.22 | $146.65 |
52-Week Low | $84.05 | $0.68 |
Typical Hold Time | 25 Days | 26 Days |
Enterprise Value | $3.08B | -$1.52M |
Dividend Yield | 2.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DAC trades at $169.09, up 2.8% today, with a bullish technical signal and strong fundamental metrics. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $7.29 exceeding the $6.80 estimate. Valuation ratios are attractive, including a P/E of 5.76 and P/B of 0.76, while profitability remains high with a net income margin of 51.26%. Recent news highlights dividend declarations and institutional investment interest.
The outlook is positive given earnings momentum and shareholder returns via dividends, but risks include shipping market volatility and reliance on global trade flows. Analyst consensus is evenly split between Buy and Hold ratings, suggesting cautious optimism amid strong operational performance.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
